Literature DB >> 17827154

Differential distribution of unmodified and phosphorylated histone deacetylase 2 in chromatin.

Jian-Min Sun1, Hou Yu Chen, James R Davie.   

Abstract

Histone deacetylase 2 (HDAC2) is one of the histone-modifying enzymes that regulate gene expression by remodeling chromatin structure. Along with HDAC1, HDAC2 is found in the Sin3 and NuRD multiprotein complexes, which are recruited to promoters by DNA-binding proteins. In this study, we show that the majority of HDAC2 in human breast cancer cells is not phosphorylated. However, the minor population of HDAC2, preferentially cross-linked to DNA by cisplatin, is mono-, di-, or tri-phosphorylated. Furthermore, HDAC2 phosphorylation is required for formation of Sin3 and NuRD complexes and recruitment to promoters by transcription factors including p53, Rb, YY1, NF-kappaB, Sp1, and Sp3. Unmodified HDAC2 requires linker DNA to associate with chromatin but is not cross-linked to DNA by formaldehyde. We provide evidence that unmodified HDAC2 is associated with the coding region of transcribed genes, whereas phosphorylated HDAC2 is primarily recruited to promoters.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17827154     DOI: 10.1074/jbc.M703549200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

1.  Resveratrol, through NF-Y/p53/Sin3/HDAC1 complex phosphorylation, inhibits estrogen receptor alpha gene expression via p38MAPK/CK2 signaling in human breast cancer cells.

Authors:  Francesca De Amicis; Francesca Giordano; Adele Vivacqua; Michele Pellegrino; Maria Luisa Panno; Donatella Tramontano; Suzanne A W Fuqua; Sebastiano Andò
Journal:  FASEB J       Date:  2011-07-07       Impact factor: 5.191

2.  Protein kinase CK2-mediated phosphorylation of HDAC2 regulates co-repressor formation, deacetylase activity and acetylation of HDAC2 by cigarette smoke and aldehydes.

Authors:  David Adenuga; Irfan Rahman
Journal:  Arch Biochem Biophys       Date:  2010-04-11       Impact factor: 4.013

3.  YY1 plays an essential role at all stages of B-cell differentiation.

Authors:  Eden Kleiman; Haiqun Jia; Salvatore Loguercio; Andrew I Su; Ann J Feeney
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-22       Impact factor: 11.205

4.  Hopx and Hdac2 interact to modulate Gata4 acetylation and embryonic cardiac myocyte proliferation.

Authors:  Chinmay M Trivedi; Wenting Zhu; Qiaohong Wang; Cheng Jia; Hae Jin Kee; Li Li; Sridhar Hannenhalli; Jonathan A Epstein
Journal:  Dev Cell       Date:  2010-09-14       Impact factor: 12.270

Review 5.  Structure and function insights into the NuRD chromatin remodeling complex.

Authors:  Morgan P Torchy; Ali Hamiche; Bruno P Klaholz
Journal:  Cell Mol Life Sci       Date:  2015-03-22       Impact factor: 9.261

6.  Protein kinase CK2 regulates the dimerization of histone deacetylase 1 (HDAC1) and HDAC2 during mitosis.

Authors:  Dilshad H Khan; Shihua He; Jenny Yu; Stefan Winter; Wenguang Cao; Christian Seiser; James R Davie
Journal:  J Biol Chem       Date:  2013-04-23       Impact factor: 5.157

7.  Structure of Arabidopsis HISTONE DEACETYLASE15.

Authors:  Chia-Yang Chen; Yi-Tsung Tu; Jhe-Cheng Hsu; Heng-Chen Hung; Ting-Chun Liu; Yu-Hsuan Lee; Chun-Chi Chou; Yi-Sheng Cheng; Keqiang Wu
Journal:  Plant Physiol       Date:  2020-09-02       Impact factor: 8.340

8.  Histone deacetylase 2 is phosphorylated, ubiquitinated, and degraded by cigarette smoke.

Authors:  David Adenuga; Hongwei Yao; Thomas H March; Jeanclare Seagrave; Irfan Rahman
Journal:  Am J Respir Cell Mol Biol       Date:  2008-10-16       Impact factor: 6.914

Review 9.  Unique functional roles for class I and class II histone deacetylases in central nervous system development and function.

Authors:  Michael J Morris; Lisa M Monteggia
Journal:  Int J Dev Neurosci       Date:  2013-03-04       Impact factor: 2.457

Review 10.  Histone deacetylase‑2: A potential regulator and therapeutic target in liver disease (Review).

Authors:  Ya-Ru Liu; Jie-Quan Wang; Zhao-Gang Huang; Ruo-Nan Chen; Xi Cao; Dong-Chun Zhu; Hai-Xia Yu; Xiu-Rong Wang; Hai-Yun Zhou; Quan Xia; Jun Li
Journal:  Int J Mol Med       Date:  2021-05-20       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.